BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34949766)

  • 1. Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients.
    Fuchs TL; Maclean F; Turchini J; Vargas AC; Bhattarai S; Agaimy A; Hartmann A; Kao CS; Ellis C; Bonert M; Leroy X; Kunju LP; Schwartz L; Matsika A; Williamson SR; Rao P; Divatia M; Guarch R; Algaba F; Balancin ML; Zhou M; Samaratunga H; da Cunha IW; Brimo F; Ryan A; Clouston D; Aron M; O'Donnell M; Chan E; Hirsch MS; Moch H; Pang CY; Wah C; Yin W; Perry-Keene J; Yilmaz A; Chou A; Clarkson A; van der Westhuizen G; Morrison E; Zwi J; Hes O; Trpkov K; Gill AJ
    Mod Pathol; 2022 Jun; 35(6):836-849. PubMed ID: 34949766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients.
    Gill AJ; Hes O; Papathomas T; Šedivcová M; Tan PH; Agaimy A; Andresen PA; Kedziora A; Clarkson A; Toon CW; Sioson L; Watson N; Chou A; Paik J; Clifton-Bligh RJ; Robinson BG; Benn DE; Hills K; Maclean F; Niemeijer ND; Vlatkovic L; Hartmann A; Corssmit EP; van Leenders GJ; Przybycin C; McKenney JK; Magi-Galluzzi C; Yilmaz A; Yu D; Nicoll KD; Yong JL; Sibony M; Yakirevich E; Fleming S; Chow CW; Miettinen M; Michal M; Trpkov K
    Am J Surg Pathol; 2014 Dec; 38(12):1588-602. PubMed ID: 25025441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma.
    Williamson SR; Eble JN; Amin MB; Gupta NS; Smith SC; Sholl LM; Montironi R; Hirsch MS; Hornick JL
    Mod Pathol; 2015 Jan; 28(1):80-94. PubMed ID: 25034258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of succinate dehydrogenase-deficient renal cell carcinoma with focus on clinical and pathobiological aspects.
    Kuroda N; Yorita K; Nagasaki M; Harada Y; Ohe C; Jeruc J; Raspollini MR; Michal M; Hes O; Amin MB
    Pol J Pathol; 2016 Mar; 67(1):3-7. PubMed ID: 27179267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-evaluation of 33 'unclassified' eosinophilic renal cell carcinomas in young patients.
    Li Y; Reuter VE; Matoso A; Netto GJ; Epstein JI; Argani P
    Histopathology; 2018 Mar; 72(4):588-600. PubMed ID: 28898443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary succinate dehydrogenase-deficient renal cell carcinoma.
    Rogala J; Zhou M
    Semin Diagn Pathol; 2024 Jan; 41(1):32-41. PubMed ID: 37981479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling.
    Yakirevich E; Ali SM; Mega A; McMahon C; Brodsky AS; Ross JS; Allen J; Elvin JA; Safran H; Resnick MB
    Am J Surg Pathol; 2015 Jun; 39(6):858-63. PubMed ID: 25724004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of succinate dehydrogenase and fumarate hydratase-deficient renal cell carcinoma based on immunohistochemical screening with SDHA/SDHB and FH/2SC.
    Gupta S; Swanson AA; Chen YB; Lopez T; Milosevic D; Kipp BR; Leibovich BC; Thompson RH; Herrera-Hernandez L; Cheville JC; Jimenez RE
    Hum Pathol; 2019 Sep; 91():114-122. PubMed ID: 31299266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Succinate dehydrogenase B-deficient renal cell carcinoma: A case report with novel germline mutation.
    Iwashita H; Okudela K; Matsumura M; Yamanaka S; Sawazumi T; Enaka M; Udaka N; Miyake A; Hibiya T; Miyake N; Matsumoto N; Makiyama K; Yao M; Nagashima Y; Ohashi K
    Pathol Int; 2017 Nov; 67(11):585-589. PubMed ID: 28960644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma.
    Smith SC; Sirohi D; Ohe C; McHugh JB; Hornick JL; Kalariya J; Karia S; Snape K; Hodgson SV; Cani AK; Hovelson D; Luthringer DJ; Martignoni G; Chen YB; Tomlins SA; Mehra R; Amin MB
    Histopathology; 2017 Jul; 71(1):42-52. PubMed ID: 28165631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Succinate Dehydrogenase-Deficient Renal Cell Carcinoma: A Short Review.
    Wang G; Rao P
    Arch Pathol Lab Med; 2018 Oct; 142(10):1284-1288. PubMed ID: 30281364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of succinate dehydrogenase-deficient bladder paragangliomas.
    Mason EF; Sadow PM; Wagner AJ; Remillard SP; Flood TA; Belanger EC; Hornick JL; Barletta JA
    Am J Surg Pathol; 2013 Oct; 37(10):1612-8. PubMed ID: 23797725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SDH-deficient renal cell carcinoma - clinical, pathologic and genetic correlates: a case report.
    Kumar R; Bonert M; Naqvi A; Zbuk K; Kapoor A
    BMC Urol; 2018 Nov; 18(1):109. PubMed ID: 30482207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Succinate dehydrogenase (SDH)-deficient renal cell carcinoma].
    Agaimy A
    Pathologe; 2016 Mar; 37(2):144-52. PubMed ID: 26979428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Succinate dehydrogenase-deficient renal cell carcinoma:a clinicopathological, ultrastructural and molecular analysis].
    Wang XT; Wang X; Zhang RS; Cheng K; Xia QY; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):12-16. PubMed ID: 34979747
    [No Abstract]   [Full Text] [Related]  

  • 16. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.
    Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O
    Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive/retained SDHB immunostaining in renal cell carcinomas associated to germline SDHB-deficiency: case report.
    Ugarte-Camara M; Fernandez-Prado R; Lorda I; Rossello G; Gonzalez-Enguita C; Cannata-Ortiz P; Ortiz A
    Diagn Pathol; 2019 May; 14(1):42. PubMed ID: 31092265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis.
    Papathomas TG; Gaal J; Corssmit EP; Oudijk L; Korpershoek E; Heimdal K; Bayley JP; Morreau H; van Dooren M; Papaspyrou K; Schreiner T; Hansen T; Andresen PA; Restuccia DF; van Kessel I; van Leenders GJ; Kros JM; Looijenga LH; Hofland LJ; Mann W; van Nederveen FH; Mete O; Asa SL; de Krijger RR; Dinjens WN
    Eur J Endocrinol; 2014 Jan; 170(1):1-12. PubMed ID: 24096523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary Characterization and Recategorization of Adult Unclassified Renal Cell Carcinoma.
    Kwon R; Argani P; Epstein JI; Lombardo KA; Wang X; Pierorazio PM; Mehra R; Matoso A
    Am J Surg Pathol; 2021 Apr; 45(4):450-462. PubMed ID: 33239504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single nucleotide variants of succinate dehydrogenase A gene in renal cell carcinoma.
    Kamai T; Higashi S; Murakami S; Arai K; Namatame T; Kijima T; Abe H; Jamiyan T; Ishida K; Shirataki H; Yoshida KI
    Cancer Sci; 2021 Aug; 112(8):3375-3387. PubMed ID: 34014604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.